Skip to main content

Astrazeneca Pharma I

Healthcare NSE:ASTRAZEN

8401.00INR
-208.00 ( -2.42%)

Last update at March 13, 2026, midnight

Day Range

8292.008579.00
LowHigh

52 Week Range

6596.95 10654.58
LowHigh

Fundamentals

  • Previous Close 8609.00
  • Market Cap 210752.59M
  • Volume6,947
  • P/E Ratio 105.80
  • EBITDA 3141.20M
  • Revenue TTM 20061.70M
  • Revenue Per Share TTM 802.69
  • Gross Profit TTM 8738.50M
  • Diluted EPS TTM 79.57

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 1563.60M 2195.40M 1341.00M 830.40M 1270.90M
Net income 1157.40M 1615.10M 992.90M 616.00M 933.00M
Total Revenue 17162.90M 12955.30M 10029.70M 8056.00M 8085.60M
Gross Profit 7532.80M 6222.70M 5777.10M 4481.40M 4780.20M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 15181.20M 10780.30M 9848.85M 8565.60M 7747.10M
Intangible assets 6.60M 21.10M - - -
Other current assets 561.70M 299.60M 266.18M 187.45M 154.04M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 305.70M 52.30M 519.21M 960.80M 2688.40M
Operating Cash 653.60M 278.70M 582.98M 1008.00M 1047.80M
Free Cash Flow 636.10M 171.10M 497.78M 911.80M 970.70M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
ASTRAZEN
Astrazeneca Pharma I 		-208.00 -2.42% 8401.00 210752.59 105.80
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-23.70 -1.30% 1801.60 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-211.00 -3.36% 6071.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-56.00 -1.26% 4390.00 1362716.66 63.48
CIPLA
Cipla Limited 		-9.60 -0.72% 1314.70 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.